286
V. S. Arvapalli et al. / Tetrahedron Letters 51 (2010) 284–286
H
POCl3
- HCl
N
R
N
R
N
N
N
N
R
O
Cl
7
8
2
N
N
N
N
N
R
N
R
R
9
3
10
Scheme 3. Proposed mechanism of the cyclization step.
labeling NMR experiments.22 Picolinamides 2 is converted to
imidoyl chlorides 7 which upon loss of hydrogen chloride gener-
ates nitrile ylides 8–10 in different resonance forms, which then
cyclized to 3-substituted-imidazo[1,5-a]pyridines 3.
In conclusion, we have applied a convenient microwave-as-
sisted organic synthesis to the preparation of 3-substituted-imi-
dazo[1,5-a]pyridines. The scope and limitations of this method
were presented.
14. (a) Krapcho, A. P.; Powell, J. R. Tetrahedron Lett. 1986, 27, 3713; (b) Bluhm, M.
E.; Ciesielski, M.; Gorls, H.; Doring, M. Angew. Chem., Int. Ed. 2002, 41, 2962.
15. Katritzky, A. R.; Qiu, G. J. Org. Chem. 2001, 66, 2862.
16. Wang, J.; Mason, R.; VanDerveer, D.; Feng, K.; Bu, X. R. J. Org. Chem. 2003, 68,
5415.
17. (a) Siddiqui, S. A.; Potewar, T. M.; Lahoti, R. J.; Srinivasan, K. V. Synthesis 2006,
2849; (b) Wang, J.; Dyers, L., Jr.; Mason, R., Jr.; Amoyaw, P.; Bu, X. R. J. Org.
Chem. 2005, 70, 2353.
18. Shibahara, F.; Sugiura, R.; Yamaguchi, E.; Kitagawa, A.; Murai, T. J. Org. Chem.
2009, 74, 3566.
19. Crawforth, J. M.; Paoletti, M. Tetrahedron Lett. 2009, 50, 4916.
20. A representative procedure for the synthesis of N-benzylpicolinamide (2a) is
presented as follows: Methyl picolinate (1, 568 mg, 4.15 mmol) and
benzylamine (488 mg, 4.56 mmol) in 1,4-dioxane (2 mL) were heated with
stirring at 200 °C for 1 h in the Biotage InitiatorTM microwave reactor. After
cooling, the contents of the reaction vessel were poured onto water and the
aqueous mixture was extracted with methylene chloride. The organic phase
was washed with saturated aqueous brine solution, dried over Na2SO4, and
concentrated in vacuo. The residue was purified by column chromatography
(silica gel, ethyl acetate/hexanes) to give N-benzylpicolinamide (2a, 529 mg,
60%): 1H NMR (CDCl3, 300 MHz): d 4.67 (d, J = 6.1 Hz, 2H), 7.26–7.44 (m, 6H),
7.85 (td, J = 7.7 Hz, 1.7 Hz, 1H), 8.23 (dd, J = 7.8 Hz, 0.9 Hz, 1H), 8.38 (br s, 1H),
8.52 (ddd, J = 4.7 Hz, 1.6 Hz, 0.9 Hz, 1H), ESI-MS: m/z 213 [M+H]+.
References and notes
1. (a) Nakatsuka, M.; Shimamura, T. Jpn. Kokai Tokkyo Koho JP 2001035664;
Chem. Abstr. 2001, 134, 170632.; (b) Tominaga, G.; Kohama, R.; Takano, A. Jpn.
Kokai Tokkyo Koho JP 2001006877; Chem. Abstr. 2001, 134, 93136.; (c)
Kitazawa, D.; Tominaga, G.; Takano, A. Jpn. Kokai Tokkyo Koho JP
2001057292; Chem. Abstr. 2001, 134, 200276.
2. Nakamura, H.; Yamamoto, H. PCT Int. Appl. WO 2005043630; Chem. Abstr.
2005, 142, 440277.
3. (a) Alcarazo, M.; Roseblade, S. J.; Cowley, A. R.; Fernandez, R.; Brown, J. M.;
Lassaletta, J. M. J. Am. Chem. Soc. 2005, 127, 3290; (b) Burstein, C.; Lehmann, C.
W.; Glorius, F. Tetrahedron 2005, 61, 6207; (c) Hahn, F. E. Angew. Chem., Int. Ed.
2006, 45, 1348.
4. Davey, D.; Erhardt, P. W.; Lumma, W. C., Jr.; Wiggins, J.; Sullivan, M.; Pang, D.;
Cantor, E. J. Med. Chem. 1987, 30, 1337.
5. Browne, L. J.; Gude, C.; Rodriguez, H.; Steele, R. E. J. Med. Chem. 1991, 34, 725.
6. Ford, N. F.; Browne, L. J.; Campbell, T.; Gemenden, C.; Goldstein, R.; Gude, C.;
Wasley, J. W. F. J. Med. Chem. 1985, 28, 164.
7. Kim, D.; Wang, L.; Hale, J. J.; Lynch, C. L.; Budhu, R. J.; MacCoss, M.; Mills, S. G.;
Malkowitz, L.; Gould, S. L.; DeMartino, J. A.; Springer, M. S.; Hazuda, D.; Miller,
M.; Kessler, J.; Hrin, R. C.; Carver, G.; Carella, A.; Henry, K.; Lineberger, J.;
Schleif, W. A.; Emini, E. A. Bioorg. Med. Chem. Lett. 2005, 15, 2129.
8. Ashauer, U.; Wolff, C.; Haller, R. Arch. Pharm. (Weinheim) 1986, 319, 43.
9. Bower, J. D.; Ramage, C. R. J. Chem. Soc. 1955, 2834.
21.
A representative procedure for the synthesis of a 3-phenylimidazo[1,5-
a]pyridine (3a) is presented as follows: A mixture of N-benzylpicolinamide
(2a, 100 mg, 0.471 mmol) and phosphorus oxychloride (2 mL, 21.5 mmol) was
heated with stirring at 150 °C for 45 min in Biotage InitiatorTM microwave
reactor. After cooling, the mixture was concentrated in vacuo, and water
(10 mL) was added to the residue. The pH of the resulting solution was
adjusted to 7–8 with concentrated NH4OH and the mixture was extracted with
ethyl acetate (3 ꢀ 10 mL). The combined organic extracts were washed with
brine, dried over magnesium sulfate, and concentrated in vacuo. The residue
was purified by column chromatography (silica gel, ethyl acetate/hexanes) to
give 3-phenylimidazo[1,5-a]pyridine (3a, 84 mg, 92%): 1H NMR (CDCl3,
300 MHz):
d 6.55 (td, J = 7.4 Hz, 1.2 Hz, 1H), 6.72 (ddd, J = 9.1 Hz, 6.4 Hz,
0.8 Hz, 1H), 7.42–7.56 (m, 5H), 7.80 (dd, J = 3.5 Hz, 1.5 Hz, 2H), 8.26 (dd,
J = 7.3 Hz, 0.9 Hz, 1H); ESI-MS: m/z 195 [M+H]+.
10. Winterfeld, K.; Franzke, H. Angew. Chem. 1963, 75, 1101.
22. (a) Tachikawa, R.; Tanaka, S.; Terada, A. Heterocycles 1981, 15, 369; (b)
Benincori, T.; Brenna, E.; Sannicolo, F. J. Chem. Soc., Perkin Trans. 1 1993, 675.
23. Guo, Z.; Dowdy, E. D.; Li, W.-S.; Polniaszek, R.; Delaney, E. Tetrahedron Lett.
2001, 42, 1843.
11. Bourdais, J.; Omar, A.-M. M. E. J. Heterocycl. Chem. 1980, 17, 555.
12. (a) El Khadem, H. S.; Kawal, J.; Swartz, D. L. Heterocycles 1989, 28, 239; (b)
Moulin, A.; Garcia, S.; Martinez, J.; Fehrentz, J.-A. Synthesis 2007, 2667.
13. Shibahara, F.; Kitagawa, A.; Yamaguchi, E.; Murai, T. Org. Lett. 2006, 8, 5621.